Showing 61 - 80 results of 1,859 for search '"Immunotherapy"', query time: 0.05s Refine Results
  1. 61

    MicroRNAs as Immunotherapy Targets for Treating Gastroenterological Cancers by Yixin Yang, Christopher Alderman, Ayoub Sehlaoui, Yuan Xiao, Wei Wang

    Published 2018-01-01
    “…Since aberrant expressions of miRNAs are found in gastroenterological cancers and miRNAs have been shown to regulate antitumor immunity, the combination therapy combining the traditional antibody-based immunotherapy and novel miRNA-based immunotherapy is promising for achieving clinical success. …”
    Get full text
    Article
  2. 62

    Immunotherapy of Brain Cancers: The Past, the Present, and Future Directions by Lisheng Ge, Neil Hoa, Daniela A. Bota, Josephine Natividad, Andrew Howat, Martin R. Jadus

    Published 2010-01-01
    “…For some patients, immunotherapy has worked for them while not showing long-term toxicity. …”
    Get full text
    Article
  3. 63

    Food allergens and oral immunotherapy as indicators of eosinophilic oesophagitis by Andrzej Kuźmiński, Justyna Przybyszewska, Zbigniew Bartuzi

    Published 2024-05-01
    “…The main indicators of EoE are food allergens and in recent years the extremely important role of oral immunotherapy (OIT) in the development of this disease has also been increasingly raised. …”
    Get full text
    Article
  4. 64

    Toll-Like Receptor-Based Strategies for Cancer Immunotherapy by Saghar Pahlavanneshan, Ali Sayadmanesh, Hamidreza Ebrahimiyan, Mohsen Basiri

    Published 2021-01-01
    “…Altogether, reviewed publications suggest that TLRs make a potential target for the immunotherapy of cancer.…”
    Get full text
    Article
  5. 65
  6. 66
  7. 67

    Navigating the landscape of neoadjuvant immunotherapy for NSCLC: progress and controversies by Yuzhu Chen, Fei Qi, Chenhao Sun, Peng Jiang, Xiangyu Xue, Xiaomei Yang, Xiaomi Li, Xin He, Yishuo Wang, Tongmei Zhang

    Published 2025-01-01
    “…Careful consideration is essential to maximize the benefits of immunotherapy for patients with resectable NSCLC. This article offers a detailed overview of recent advancements in neoadjuvant immunotherapy for resectable NSCLC. …”
    Get full text
    Article
  8. 68
  9. 69

    New insight in immunotherapy and combine therapy in colorectal cancer by Kai Ji, Kai Ji, Hang Jia, Zixuan Liu, Guanyu Yu, Rongbo Wen, Tianshuai Zhang, Zhiying Peng, Wenjiang Man, Wenjiang Man, Yucheng Tian, Yucheng Tian, Can Wang, Can Wang, Qianlong Ling, Wei Zhang, Leqi Zhou, Mulin Liu, Bing Zhu

    Published 2025-01-01
    “…These therapies have proven safer and more effective than traditional radiotherapy and targeted treatments. Immunotherapies like pembrolizumab, nivolumab, and ipilimumab have pioneered new treatment avenues, potentially improving patient outcomes and quality of life. …”
    Get full text
    Article
  10. 70

    Dual Roles of IL-27 in Cancer Biology and Immunotherapy by Marina Fabbi, Grazia Carbotti, Silvano Ferrini

    Published 2017-01-01
    “…Here, we will summarize IL-27 biological activities and its functional overlaps with the IFNs and discuss its dual role in tumors in the light of potential applications to cancer immunotherapy.…”
    Get full text
    Article
  11. 71
  12. 72
  13. 73
  14. 74

    Exploring novel immunotherapy biomarker candidates induced by cancer deformation. by Se Min Kim, Namu Park, Hye Bin Park, JuKyung Lee, Changho Chun, Kyung Hoon Kim, Jong Seob Choi, Hyung Jin Kim, Sekyu Choi, Jung Hyun Lee

    Published 2024-01-01
    “…This research is primarily focused on identifying new biomarkers vital for immunotherapy, with the aim of developing tailored treatments specifically for TNBC, such as those targeting the PD-1/PD-L1 pathway. …”
    Get full text
    Article
  15. 75
  16. 76
  17. 77
  18. 78

    The “Trojan Horse” Approach to Tumor Immunotherapy: Targeting the Tumor Microenvironment by Delia Nelson, Scott Fisher, Bruce Robinson

    Published 2014-01-01
    “…Most anticancer therapies including immunotherapies are given systemically; yet therapies given directly into tumors may be more effective, particularly those that overcome natural suppressive factors in the tumor microenvironment. …”
    Get full text
    Article
  19. 79
  20. 80